Nestlé VMS business acquired by Yellow Wood Partners
Context
Announced in September 2026, the corporate carve-out agreement entered into between Yellow Wood Partners and Nestlé executes the acquisition of Nestlé's mainstream vitamins, minerals, and supplements business, designated as the Holistic Health portfolio. The transaction involves Yellow Wood Partners acquiring full ownership of the target business, which generated annual turnover of $1–10bn in 2025. Structurally, the divestiture encompasses the complete transfer of seven mainstream consumer supplement brands alongside dedicated manufacturing, packaging, warehousing, and distribution infrastructure. Under the leadership of Chief Executive Officer Philipp Navratil, the divestment enables Nestlé to refocus corporate capital and research capabilities on premium, science-led health and wellness categories, retaining specialized brands such as Solgar and Pure Encapsulations. For Yellow Wood Partners, represented by partner Tad Yanagi, the investment thesis focuses on applying the firm's Consumer Operating DNA framework to scale the acquired portfolio as an independent corporate entity, addressing expanding consumer adoption across functional health, joint health, hydration, and nutritional wellness. The integration strategy aims to capture organic growth across mass retail, pharmacy, and grocery channels, utilizing the acquired private-label manufacturing capacity to support contracted product supply agreements. The completion of this cross-border carve-out remains subject to applicable regulatory clearances and customary closing conditions, with final closing projected for the first half of 2027.
-> Deep-dive in Healthcare & Pharma market trends
Target
Founded in Vevey, the Nestlé VMS (Vitamins, Minerals and Supplements) business operates a mainstream vitamins, minerals and supplements portfolio serving the general‑consumer market. The unit comprises seven established brands—Nature’s Bounty, Osteo Bi‑Flex, Ester‑C, Gard, Nuun, Puritan’s Pride and Sisu—plus a private‑label supplement line in the United States. It maintains dedicated manufacturing, packaging, warehousing and distribution facilities that support sales primarily in the U.S., with additional presence in Canada and China. The business model combines brand ownership with in‑house production and logistics, enabling direct supply to retail channels and e‑commerce platforms. By integrating formulation, quality control, and packaging under one operational umbrella, the company delivers a consistent product range across multiple dosage forms while leveraging scale in procurement and distribution. The operation employs a workforce spread across manufacturing sites and distribution centres, and it manages a supply chain that sources raw ingredients, conducts blending and encapsulation, and distributes finished goods to national and international retailers.
Ent. Value
$1–10bn
Equity Value
[members only]
Multiples
EV / Revenue
below 1.5x
EV / EBITDA
[members only]
EV / EBIT
[members only]
Historical Financials (USD)
Other operations with Nestle
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 07/2026 | PLATINUM EQUITY / NESTLE | PERANEL EX NESTLE WATER | FRANCE | Soft Drinks |
| 06/2026 | NESTLE | YFOOD LABS | GERMANY | Food Products |
| 05/2021 | NESTLE | NUUN | UNITED STATES | Soft Drinks |
| 04/2021 | NESTLE | THE BOUNTIFUL COMPANY | UNITED STATES | Nutrition & Dietary Supplements |
| 02/2021 | SILVER LAKE / NESTLE | IVC EVIDENSIA | UNITED KINGDOM | Vet Clinics |
| 09/2020 | NESTLE | IM HEALTHSCIENCE | UNITED STATES | Nutrition & Dietary Supplements |
| 09/2017 | NESTLE | SWEET EARTH | UNITED STATES | Food Products |
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 10/2026 | APHEON | HAGER & MEISINGER | GERMANY | Medical Consumables |
| 10/2026 | NEXTSTAGE | CORAVIA | FRANCE | Medical Consumables |
| 09/2026 | TELIX PHARMACEUTICALS | ITM ISOTOPE TECHNOLOGIES | GERMANY | Pharma & Biotech |
| 08/2026 | TELEDYNE TECHNOLOGIES INCORPORATED | VAREX IMAGING | UNITED STATES | Diagnostic Equipment |
| 08/2026 | ZIMMER BIOMET | MONOGRAM TECHNOLOGIES | UNITED STATES | Medical Devices |
| 08/2026 | WISE EQUITY | E-PHARMA TRENTO | ITALY | CDMO |
| 08/2026 | STADA | ORIFARM VMS | DENMARK | Nutrition & Dietary Supplements |
| 08/2026 | KKR | INTEGER | UNITED STATES | Medical Devices |
| 07/2026 | INFLEXION | PRIMED | GERMANY | Medical Consumables |
| 07/2026 | BAIN CAPITAL | VITABIOTICS | UNITED KINGDOM | Nutrition & Dietary Supplements |
REFERENCES
Valuation range: EV $1–10bn
Revenue range: $1–10bn
EV/Revenue range: below 1.5x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Nestlé VMS business by Yellow Wood Partners are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: nestlé vms business
FAQ
What transaction does this page cover?
How was the acquisition of Nestlé VMS business by Yellow Wood Partners valued, and what multiples were paid?
What was Nestlé VMS business’s revenue at the time of the deal?
What sources support the information on this transaction?
What is mynth?